KIORA PHARMACEUTICALS, INC. Lessee, Operating Lease, Liability, Undiscounted Excess Amount
KIORA PHARMACEUTICALS, INC. (KPRX) had Lessee, Operating Lease, Liability, Undiscounted Excess Amount of $19.03 thousand as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Notes › Leases
us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount · last filed 2026-08-07
- 2026-06-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $19.03K.
- 2026-03-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $24.15K.
- 2025-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $27.22K.
- 2025-09-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $33.00K.
| Period end | Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
|---|---|
| 2026-06-30 | $19.03K 10-Q · filed 2026-08-07 |
| 2026-03-31 | $24.15K 10-Q · filed 2026-05-08 |
| 2025-12-31 | $27.22K 10-K · filed 2026-03-25 |
| 2025-09-30 | $33.00K 10-Q · filed 2025-11-07 |
| 2025-06-30 | $39.22K 10-Q · filed 2025-08-08 |
| 2025-03-31 | $12.71K 10-Q · filed 2025-05-09 |
| 2024-12-31 | $7.42K 10-K · filed 2025-03-25 |
| 2024-09-30 | $9.32K 10-Q · filed 2024-11-08 |
| 2024-06-30 | $10.51K 10-Q · filed 2024-08-09 |
| 2024-03-31 | $12.41K 10-Q · filed 2024-05-10 |
| 2023-12-31 | $14.76K 10-K · filed 2024-03-25 |
| 2023-06-30 | $176.00 10-Q · filed 2023-08-08 |
| 2023-03-31 | $785.00 10-Q · filed 2023-05-09 |
| 2022-12-31 | $1.83K 10-K · filed 2023-03-23 |
| 2021-12-31 | $19.01K 10-K/A · filed 2022-07-07 |
| 2021-09-30 | $25.16K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $32.58K 10-Q · filed 2021-08-12 |
| 2021-03-31 | $34.85K 10-Q · filed 2021-05-12 |
| 2020-12-31 | $8.35K 10-K · filed 2021-03-25 |
| 2020-09-30 | $1.71K 10-Q · filed 2020-11-09 |
| 2020-06-30 | $3.94K 10-Q · filed 2020-08-06 |
| 2020-03-31 | $4.65K 10-Q · filed 2020-05-06 |
| 2019-12-31 | $2.46K 10-K · filed 2020-03-04 |
| 2019-09-30 | $3.84K 10-Q · filed 2019-11-07 |
| 2019-06-30 | $4.56K 10-Q · filed 2019-08-08 |
| 2019-03-31 | $3.78K 10-Q · filed 2019-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |